Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
11.70
-7.25
-61.97%
Share Warrants & Outstandings
Total Reserve
-6.44
17.27
-23.71
-137.29%
Shareholder's Funds
-1.99
29.72
-31.71
-106.70%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.09
0.16
7.93
4,956.25%
Secured Loans
5.10
0.16
4.94
3,087.50%
Unsecured Loans
2.99
0.00
2.99
0.00%
Deferred Tax Assets / Liabilities
-0.19
1.16
-1.35
-116.38%
Other Long Term Liabilities
0.00
0.25
-0.25
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.51
1.57
5.94
378.34%
Current Liabilities
Trade Payables
10.22
11.67
-1.45
-12.43%
Other Current Liabilities
2.24
2.51
-0.27
-10.76%
Short Term Borrowings
0.00
11.97
-11.97
-100.00%
Short Term Provisions
0.59
0.00
0.59
0.00%
Total Current Liabilities
13.04
26.15
-13.11
-50.13%
Total Liabilities
18.56
57.44
-38.88
-67.69%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.69
18.37
-0.68
-3.70%
Less: Accumulated Depreciation
9.72
8.24
1.48
17.96%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.97
10.13
-2.16
-21.32%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.22
-2.22
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
0.27
0.13
48.15%
Long Term Loans & Advances
0.18
0.00
0.18
0.00%
Other Non Current Assets
0.00
1.41
-1.41
-100.00%
Total Non-Current Assets
8.56
14.03
-5.47
-38.99%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.31
7.49
-4.18
-55.81%
Sundry Debtors
1.28
24.75
-23.47
-94.83%
Cash and Bank
0.09
3.27
-3.18
-97.25%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
5.32
7.91
-2.59
-32.74%
Total Current Assets
10.00
43.42
-33.42
-76.97%
Net Current Assets (Including Current Investments)
-3.03
17.27
-20.30
-117.54%
Total Current Assets Excluding Current Investments
10.00
43.42
-33.42
-76.97%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18.56
57.44
-38.88
-67.69%
Contingent Liabilities
0.00
0.09
-0.09
-100.00%
Total Debt
7.32
12.13
-4.81
-39.65%
Book Value per share (adjusted)
-4.47
24.76
-29.23
-118.05%
Annual - Borrowings
Borrowings 7.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Annual - Investments
Investments 0.40 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
